High priority for hepatitis C screening in safety net hospitals: Results from a prospective cohort of 4582 hospitalized baby boomers

Hepatology

Volumn 62, Issue 5, 2015, Pages 1388-1395

  Turner, Barbara J ^a   Taylor, Barbara S ^a   Hanson, Joshua ^a   Liang, Yuanyuan ^a   Veerapaneni, Poornachand ^a   Villarreal, Roberto ^b   Perez, Mary ^c   Hernandez, Ludivina ^a   Sandhu, Jasdeep ^a   Fiebelkorn, Kristin ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY HEALTH SYSTEM   (United States)

^c University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGE; ALCOHOL ABUSE; ALCOHOLISM; ANTIBODY SCREENING; ARTICLE; ASIAN; BABY BOOMER; CAUCASIAN; CHRONIC HEPATITIS C; FEMALE; HEALTH INSURANCE; HISPANIC; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; SAFETY NET HOSPITAL; SCREENING; SEX DIFFERENCE; VIREMIA; AGED; BLOOD; COHORT ANALYSIS; HEPATITIS C, CHRONIC; HOSPITALIZATION;

AGED; COHORT STUDIES; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 84945479872     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28018     Document Type: Article

References (37)

1. Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014;160:293-300.
2. Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis Infection. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: National Academies Press; 2010.
3. Kanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology 2011;140:1182-1188.
4. Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med 2013;368:1907-1917.
5. US Preventive Services Task Force . Screening for hepatitis C virus infection in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med 2013;159:349-357.
6. Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012;61:1-32.
7. Smith BD, Beckett GA, Yartel A, Holtzman D, Patel N, Ward JW. Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008. Am J Public Health 2014;104:474-481.
8. National Association of Public Hospitals and Health Systems. What is a safety net hospital? http://literacynet.org/hls/hls_conf_materials/WhatIsASafetyNetHospital.pdf. Accessed June 5, 2015.
9. Ditah I, Ditah F, Devaki P, Ewelukwa O, Ditah C, Njei B, et al. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol 2014;60:691-698.
10. Turner BJ, Taylor BS, Hanson JT, Perez ME, Hernandez L, Villarreal R, et al. Implementing hospital-based baby boomer hepatitis C virus screening and linkage to care: strategies, results, and costs. J Hosp Med 2015;10:510-516.
11. Taylor BS, Hanson JT, Veerapeneni P, Villarreal R, Fiebelkorn K, Turner BJ. Successes and barriers to implementation of hospital-based hepatitis C screening of baby boomers in a majority Hispanic South Texas cohort. Pub Health Rep. In press.
12. Siemens Medical Solutions Diagnostics. Advia Centaur Assay Manual. Publication no. 07063235, Rev. C, 2005-01. Malvern, PA.
13. Taylor P, Pickard G, Gammie A, Atkins M. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. J Clin Virol 2004;30:S11-S15.
14. Centers for Disease Control and Prevention. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 2013;62:362-365.
15. Aubé C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999;30:472-478.
16. Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, et al. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis 2013;57:240-246.
17. Li J, Gordon SC, Rupp LB, Zhang T, Boscarino JA, Vijayadeva V, et al.; Chronic Hepatitis Cohort Study (CHeCS) Investigators. The validity of serum markers for fibrosis staging in chronic hepatitis B and C. J Viral Hepat 2014;21:930-937.
18. Tamaki N, Kurosaki M, Matsuda S, Muraoka M, Yasui Y, Suzuki S, et al. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. J Gastroenterol 2014;49:1495-1503.
19. Macaskill P, Walter SD, Irwig L, Franco EL. Assessing the gain in diagnostic performance when combining two diagnostic tests. Stat Med 2002;21:2527-2546.
20. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis C: why does it really matter? Gut 2006;55:123-130.
21. Chen G, Khan N, Walker R, Quan H. Validating ICD coding algorithms for diabetes mellitus from administrative data. Diabetes Res Clin Pract 2010;89:189-195.
22. Brady KA, Weiner M, Turner BJ. Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals. J Infect 2009;59:62-69.
23. Coyle C, Viner K, Hughes E, Kwakwa H, Zibbell JE, Vellozzi C, et al. Identification and linkage to care of HCV-infected persons in five health centers-Philadelphia, Pennsylvania, 2012-2014. MMWR Morb Mortal Wkly Rep 2015;64:459-463.
24. Galbraith JW, Franco RA, Donnelly JP, Rodgers JB, Morgan JM, Viles AF, et al. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology 2015;61:776-82.
25. Milliman Client Report. Health care reform and hepatitis C: a convergence of risk and opportunity. http://us.milliman.com/uploadedFiles/insight/2013/convergence-of-risk-and-opportunity.pdf. Accessed June 12, 2015.
26. Kuniholm MH, Jung M, Everhart JE, Cotler S, Heiss G, McQuillan G, et al. Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies. J Infect Dis 2014;209:1585-1590.
27. Donepudi I, Paredes A, Hubbard S, Awad C, Sterling RK. Utility of evaluating HCV in an uninsured population. Dig Dis Sci 2015;60:1092-1097.
28. Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, et al. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 2008;51(Suppl. 1):17-26.
29. Verma S, Bonacini M, Govindarajan S, Kanel G, Lindsay KL, Redeker A. More advanced hepatic fibrosis in Hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis. Am J Gastroenterol 2006;101:1817-1823.
30. Kallwitz ER, Daviglus ML, Allison MA, Emory KT, Zhao L, Kuniholm MH, et al. Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage. Clin Gastroenterol Hepatol 2015;13:569-576.
31. Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 2015;239:192-202.
32. National Institute on Alcohol Abuse and Alcoholism. Alcohol and the Hispanic community. http://pubs.niaaa.nih.gov/publications/HispanicFact/hispanicFact.pdf. Accessed July 28, 20115.
33. Centers for Disease Control and Prevention. Leading causes of death and numbers of deaths, by sex, race, and Hispanic origin: United States, 1980 and 2010. http://www.cdc.gov/nchs/data/hus/2013/022.pdf. Accessed January 24, 2015.
34. Younossi ZM, Stepanova M. Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States. Clin Gastroenterol Hepatol 2010;8:718-723.
35. Ramirez AG, Munoz E, Holden AE, Adeigbe RT, Suarez L. Incidence of hepatocellular carcinoma in Texas Latinos, 1995-2010: an update. PLoS One 2014;9:e99365.
36. Kanwal F, Hoang T, Kramer J, Chrusciel T, El-Serag H, Dominitz JA, et al. The performance of process measures in hepatitis C. Am J Gastroenterol 2012;107:1512-1521.
37. Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med 2013;158:807-820.